|
🐜
|
A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
28 auth.
Mona O. Mohsen,
Ina Baļķe,
Simon Zinkhan,
Villija Zeltina,
Xuelan Liu,
Xinyue Chang,
Pascal S Krenger,
Kevin Plattner,
Zahra Gharailoo,
A. Vogt,
G. Augusto,
M. Zwicker,
S. Roongta,
Dominik A Rothen,
Romano Josi,
...
Joana J da Costa,
Janusz Sobczak,
Aleksandra Nonic,
Lee-Anne Brand,
K. Nuss,
B. Martina,
D. Speiser,
T. Kündig,
G. Jennings,
S. Walton,
M. Vogel,
A. Zeltiņš,
M. Bachmann
|
5 |
2021 |
5
🐜
|
|
🐜
|
Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine model.
10 auth.
Paul Engeroff,
Kevin Plattner,
F. Storni,
F. Thoms,
K. F. Boligan,
Lukas Muerner,
...
A. Eggel,
S. von Gunten,
M. Bachmann,
M. Vogel
|
4 |
2020 |
4
🐜
|
|
🦁
|
On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors
Kevin Plattner,
Martin F. Bachmann,
M. Vogel
|
3 |
2023 |
3
🦁
|
|
🦁
|
IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance via Fc Receptors
Kevin Plattner,
Zahra Gharailoo,
Simon Zinkhan,
Paul Engeroff,
Martin F. Bachmann,
M. Vogel
|
2 |
2022 |
2
🦁
|
|
🐬
|
Generation of a virus-like particles based vaccine against IgE.
Zahra Gharailoo,
Kevin Plattner,
G. Augusto,
Paul Engeroff,
Monique Vogel,
Martin F Bachmann
|
2 |
2024 |
2
🐬
|
|
🦁
|
IgE glycosylation is essential for the function of omalizumab
8 auth.
Kevin Plattner,
G. Augusto,
Lukas Muerner,
S. von Gunten,
Lukas Jörg,
Paul Engeroff,
...
Martin F. Bachmann,
M. Vogel
|
2 |
2023 |
2
🦁
|
